Quoi de neuf ?

Bienvenue sur Psychonaut.fr !

En vous enregistrant, vous pourrez discuter de psychotropes, écrire vos meilleurs trip-reports et mieux connaitre la communauté

Je m'inscris!

RC's / NPS et décès en Europe (rapport OEDT)

  • Auteur de la discussion Ji-doo
  • Date de début
J

Ji-doo

Invité
Un rapport de l'OEDT attire l'attention particulèrement sur 4 molécules qui sont liées à une centaine de décès en Europe (+ une centaine d'intoxications).


25I-NBOMe, a substituted phenethylamine drug with apparent hallucinogenic effects, has been available on the EU drug market since at least May 2012 and has been detected in 23 EU Member States and Norway. Severe toxicity associated with its use has been reported in four Member States and three deaths associated with the drug have been reported.

AH-7921, a synthetic opioid drug, has been available in the EU since at least July 2012 and has been detected in seven EU Member States and Norway. In most cases, it has been seized in small quantities as a powder. Over a short period of time it has been associated with six non-fatal intoxications and 15 deaths in three countries. The similarity of AH-7921 to morphine in terms of its pharmacology is a key concern. This could play an important role in the further spread of AH-7921 by opioid users, including the injecting population.


MDPV, a stimulant drug belonging to the group of synthetic cathinone derivatives, is closely related to pyrovalerone. MDPV has been present in the EU drug market since at least November 2008 and has been detected in up to 107 non-fatal intoxications and 99 deaths (particularly in Finland and the United Kingdom). There are some indications that it has been sold as a ‘legal’ or synthetic version of cocaine. It has also been found in tablets resembling ‘ecstasy’. Large seizures (including multi-kilogram quantities) have been made at borders and police operations have targeted its supply. Most, but not all the Member States, have control measures in place at national level covering MDPV; however, its continued availability is a cause for concern.


Methoxetamine, an arylcyclohexamine drug, related in many respects to ketamine, has been available on the EU drug market since at least September 2010. It has been detected in 22 Member States, Turkey and Norway. Powder seizures have been reported including multi-kilogram quantities. One hundred and ten (110) non-fatal intoxications associated with the substance have been reported, as well as 20 deaths.


Sources:
EMCDDA | EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe
 
C

CheesePizza

Invité
J'ai bougé ton thread dans la partie RDR annonce mon chaton :)
 
J

Ji-doo

Invité
Ok, comme c'étais assez "informel", j'ai hésité pour la section, merci !
 
Haut